AL-1095
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled |
| Identifiers | |
| CAS number | 54549-19-8 |
| ATC code | None |
| PubChem | CID 3041659 |
| ChemSpider | 2304906 |
| Chemical data | |
| Formula | C20H22ClNO |
| Mol. mass | 327.139 g/mol |
|
|
|
|
| |
AL-1095 is a centrally-acting stimulant drug with comparable effects to amphetamine[1] developed by Bristol in the 1970s.[2]
[edit] See also
[edit] References
- ^ Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6.
- ^ Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry 18 (1): 71–74. doi:10.1021/jm00235a016. PMID 803245.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

